Company history
(1969–1999)
Building a strong foundation
1969
Incorporation of the company
1999
Acquisition by Marc Danchin (current Administrator), Michel Sasportes (current President) and Olivier Jaigu, marking a new phase of development
1989
Acquisition by François Danchin and development of trading activities in disposable medical components
(1999–2010)
From distribution to industrial expertise
1999
Opening of the first manufacturing site, Dialtechnic, in Mauritius (closed in 2009)
2006
Opening of Emotechnic, manufacturing site in Casablanca (Morocco)
2002
Opening of our logistics hub, Promepla Services France, initially in Le Beausset and then in Signes (France)
2009
Opening of Promedtech, manufacturing site in Tunis (Tunisia)
(2010–today)
Expansion and evolution into a Contract Design and Manufacturing Organisation (CDMO)
2013
Creation of Rocamed SAM, specialising in endo-urology (sister company divested in 2024)
2023
Acquisition of Medical Tubing (France), specialising in thermoplastic extrusion
2025
Appointment of Jacques-Henry Grislain as Chief Executive Officer / Directeur Général
2022
Acquisition of A. Hopf Kunststoffverarbeitung GmbH (Germany), specialising in injection moulding
2025
CE marking under the Medical Device Regulation (MDR) (EU) 2017/745 for nearly 90 medical device references
Trusted by MedTech Leaders
For decades, Promepla has partnered with medical device companies to design, develop, and manufacture high-quality components , assemblies, and single-use medical devices. Combining industrial expertise, advanced R&D capabilities, and a strong commitment to innovation, we have become a trusted partner to leading MedTech companies across Europe and worldwide.